Magnevist - 50419-188-02 - (Gadopentetate dimeglumine)

Alphabetical Index


Drug Information of Magnevist

Product NDC: 50419-188
Proprietary Name: Magnevist
Non Proprietary Name: Gadopentetate dimeglumine
Active Ingredient(s): 469.01    mg/mL & nbsp;   Gadopentetate dimeglumine
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION
Coding System: National Drug Codes(NDC)

Labeler Information of Magnevist

Product NDC: 50419-188
Labeler Name: Bayer HealthCare Pharmaceuticals Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA019596
Marketing Category: NDA
Start Marketing Date: 20101214

Package Information of Magnevist

Package NDC: 50419-188-02
Package Description: 20 CARTON in 1 BOX (50419-188-02) > 1 VIAL, SINGLE-DOSE in 1 CARTON > 20 mL in 1 VIAL, SINGLE-DOSE

NDC Information of Magnevist

NDC Code 50419-188-02
Proprietary Name Magnevist
Package Description 20 CARTON in 1 BOX (50419-188-02) > 1 VIAL, SINGLE-DOSE in 1 CARTON > 20 mL in 1 VIAL, SINGLE-DOSE
Product NDC 50419-188
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Gadopentetate dimeglumine
Dosage Form Name INJECTION
Route Name INTRAVENOUS
Start Marketing Date 20101214
Marketing Category Name NDA
Labeler Name Bayer HealthCare Pharmaceuticals Inc.
Substance Name GADOPENTETATE DIMEGLUMINE
Strength Number 469.01
Strength Unit mg/mL
Pharmaceutical Classes

Complete Information of Magnevist


General Information